Mirati Therapeutics, Inc. - News Releases

2020 2019 2018 2017 2016 2015 2014 2013

8/06/2020

Mirati Therapeutics Reports Second Quarter 2020 Financial Results And Recent Business Highlights

6/05/2020

Mirati Therapeutics to Present at 41st Annual Goldman Sachs Global Healthcare Conference

5/18/2020

Mirati Therapeutics Appoints Joseph A. Leveque, M.D. As Chief Medical Officer

5/15/2020

Mirati Therapeutics To Present Preclinical Data From Investigational Pipeline Of Novel Therapeutics At 2020 American Association For Cancer Research Virtual Annual Meeting II

5/07/2020

Mirati Therapeutics Reports First Quarter 2020 Financial Results And Recent Corporate Updates

2/25/2020

Mirati Therapeutics Reports Year-End 2019 Financial Results And Recent Corporate Updates

2/19/2020

Mirati Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2/15/2020

Mirati Therapeutics Announces Initial Data In Renal Cell Carcinoma From Ongoing Investigator Sponsored Clinical Trial Of Sitravatinib In Combination With Nivolumab At The 2020 ASCO Genitourinary Cancers Symposium

1/14/2020

Mirati Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares

1/09/2020

Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock

1/08/2020

Mirati Therapeutics Announces Proposed Public Offering of Common Stock

1/06/2020

Mirati Therapeutics Announces Executive Management Changes

1/02/2020

Mirati Therapeutics To Present At The 38th Annual J.P. Morgan Healthcare Conference